loadpatents
name:-0.014678001403809
name:-0.010977983474731
name:-0.0088999271392822
Panknin; Olaf Patent Filings

Panknin; Olaf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Panknin; Olaf.The latest application filed is for "high relaxivity gadolinium chelate compounds for use in magnetic resonance imaging".

Company Profile
11.13.17
  • Panknin; Olaf - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted pyrrolopyridine-derivatives
Grant 11,427,578 - Mowat , et al. August 30, 2
2022-08-30
Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors
Grant 11,311,520 - Klar , et al. April 26, 2
2022-04-26
High Relaxivity Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
App 20210221798 - BERGER; Markus ;   et al.
2021-07-22
High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
Grant 10,975,060 - Berger , et al. April 13, 2
2021-04-13
Substituted Dihydroimidazopyridinediones As Mknk1 And Mknk2 Inhibitors
App 20210085656 - KLAR; Ulrich ;   et al.
2021-03-25
Fused imidazoles as mIDH1 inhibitors
Grant 10,919,862 - Panknin , et al. February 16, 2
2021-02-16
Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
App 20200353104 - BERGER; MARKUS ;   et al.
2020-11-12
High Relaxivity Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
App 20200283420 - BERGER; Markus ;   et al.
2020-09-10
Gadolinium chelate compounds for use in magnetic resonance imaging
Grant 10,722,601 - Berger , et al.
2020-07-28
Substituted Dihydroimidazopyridinediones As Mknk1 And Mknk2 Inhibitors
App 20190350910 - KLAR; Ulrich ;   et al.
2019-11-21
Benzimidazol-2-amines as mIDH1 inhibitors
Grant 10,442,772 - Rehwinkel , et al. Oc
2019-10-15
5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors
Grant 10,414,734 - Panknin , et al. Sept
2019-09-17
N-Methylbenzimidazoles as mIDH1 inhibitors
Grant 10,370,339 - Ring , et al.
2019-08-06
Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
App 20190083659 - Berger; Markus ;   et al.
2019-03-21
Benzimidazol-2-amines As Midh1 Inhibitors
App 20190062285 - REHWINKEL; Hartmut ;   et al.
2019-02-28
2-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors
Grant 10,179,123 - Panknin , et al. Ja
2019-01-15
1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors
Grant 10,137,110 - Rehwinkel , et al. November 27, 2
2018-11-27
Gadolinium chelate compounds for use in magnetic resonance imaging
Grant 10,137,209 - Berger , et al. November 27, 2
2018-11-27
Fused Imidazoles As Midh1 Inhibitors
App 20180215717 - PANKNIN; Olaf ;   et al.
2018-08-02
2-aryl- And 2-arylalkyl-benzimidazoles As Midh1 Inhibitors
App 20180207137 - PANKNIN; Olaf ;   et al.
2018-07-26
5-hydroxyalkylbenzimidazoles As Midh1 Inhibitors
App 20180201585 - PANKNIN; Olaf ;   et al.
2018-07-19
New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging
App 20180169274 - BERGER; MARKUS ;   et al.
2018-06-21
N-methylbenzimidazoles As Midh1 Inhibitors
App 20180170882 - RING; Sven ;   et al.
2018-06-21
Benzimidazol-2-amines as mIDH1 inhibitors
Grant 9,957,235 - Rehwinkel , et al. May 1, 2
2018-05-01
Benzimidazol-2-amines as MIDH1 inhibitors
Grant 9,951,027 - Rehwinkel , et al. April 24, 2
2018-04-24
1-cyclohexyl-2-phenylaminobenzimidazoles As Midh1 Inhibitors For The Treatment Of Tumors
App 20170319549 - REHWINKEL; Hartmut ;   et al.
2017-11-09
Benzimidazol-2-amines As Midh1 Inhibitors
App 20170197921 - REHWINKEL; Hartmut ;   et al.
2017-07-13
Benzimidazol-2-amines As Midh1 Inhibitors
App 20170197922 - REHWINKEL; Hartmut ;   et al.
2017-07-13
Spiroindoline Derivatives For Use As Gonadotropin-releasing Hormone Receptor Antagonists
App 20160052936 - PANKNIN; Olaf ;   et al.
2016-02-25
Spiroindoline Derivatives As Gonadotropin- Releasing Hormone Receptor Antagonists
App 20140357655 - Panknin; Olaf ;   et al.
2014-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed